Diagnosis - Spotting the Fire
Based on clinical criteria; lab tests are supportive, not diagnostic.
📌 Mnemonic: CRASH & Burn
- Fever > 5 days ("Burn") PLUS ≥ 4 of the following:
- Conjunctivitis: Bilateral, non-purulent.
- Rash: Polymorphous, generalized.
- Adenopathy: Cervical, unilateral, >1.5 cm.
- Strawberry tongue & lip changes (redness, fissures).
- Hand & foot changes: Erythema, edema (acute); periungual desquamation (subacute).

⭐ Atypical/Incomplete KD: Suspect in infants with prolonged unexplained fever, even with <4 criteria. Echocardiography is crucial for diagnosis and assessing coronary artery involvement.
Initial Workup - The Lab Clues
- Acute Phase Reactants:
- ↑ ESR (often >100 mm/hr)
- ↑ CRP (>3 mg/dL)
- Complete Blood Count (CBC):
- Leukocytosis (>15,000/μL) with neutrophilia.
- Normocytic, normochromic anemia.
- Platelets: Normal or ↓ initially, then marked thrombocytosis from week 2.
- Other Key Labs:
- ↑ Transaminases (ALT)
- ↓ Albumin (<3 g/dL)
- Sterile pyuria
- CSF: Aseptic meningitis (pleocytosis)
⭐ Thrombocytosis is the most striking feature, typically appearing in the 2nd week. Platelet counts can rise to > 10 lakh/mm³.

First-Line Tx - Dousing the Flames
-
Goal: Rapidly control inflammation to prevent coronary artery aneurysms (CAA).
-
Administer within 10 days of fever onset for maximal efficacy.
-
Dual Therapy:
- Intravenous Immunoglobulin (IVIG):
- The cornerstone of treatment.
- Single large dose of 2 g/kg infused over 10-12 hours.
- Aspirin (ASA):
- Initially high-dose for anti-inflammatory effect: 80-100 mg/kg/day.
- After patient is afebrile for 48-72 hours, reduce to a low anti-platelet dose: 3-5 mg/kg/day.
- Intravenous Immunoglobulin (IVIG):
⭐ Treatment with IVIG within the first 10 days of illness reduces the incidence of coronary artery aneurysms from 25% to less than 5%.
- Management of Persistent Fever:
Refractory KD - Stubborn Embers
Defined as persistent or recrudescent fever ≥ 36-48h after completing initial IVIG infusion. Occurs in 10-20% of patients, carrying a higher risk of coronary artery aneurysms (CAA).

Management Algorithm:
⭐ Infliximab is often preferred in patients with high-risk lab markers (e.g., ↑CRP, ↑Ferritin) or early signs of CAA, as it may reduce coronary artery inflammation more rapidly than corticosteroids.
High‑Yield Points - ⚡ Biggest Takeaways
- IVIg (2 g/kg single dose) is the cornerstone of acute management, best given within 10 days of fever onset.
- Initial treatment includes high-dose aspirin (80-100 mg/kg/day) to rapidly control systemic inflammation.
- Aspirin is switched to a low, antiplatelet dose (3-5 mg/kg/day) once afebrile for 48-72 hours.
- The primary goal is preventing coronary artery aneurysms, the most feared complication.
- Baseline echocardiography is mandatory to assess for early cardiac changes.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more